SKINVISIBLE, INC. (SKVI) Executive Compensation
SKINVISIBLE, INC. (SKVI) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SKVI
CIK: 1085277
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
GreenGrowth CPAs
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerMauro Botta
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q | 0001663577-26-000248 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | FORM 10-Q | 0001663577-26-000141 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | FORM 10-K | 0001663577-26-000087 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | FORM 10-Q | 0001663577-25-000309 | View SEC Doc Filr Page |
| 10-Q | 2025-08-13 | 2025-06-30 | FORM 10-Q | 0001663577-25-000261 | View SEC Doc Filr Page |
| 10-Q | 2025-05-14 | 2025-03-31 | FORM 10-Q | 0001663577-25-000136 | View SEC Doc Filr Page |
| 10-K | 2025-04-14 | 2024-12-31 | ANNUAL REPORT | 0001663577-25-000110 | View SEC Doc Filr Page |
| NT 10-K | 2025-03-31 | 2024-12-31 | NT 10-K Filing | 0001663577-25-000088 | View SEC Doc Filr Page |
| 8-K | 2025-01-23 | 2025-01-23 | FORM 8-K | 0001663577-25-000033 | View SEC Doc Filr Page |
| 10-Q | 2024-11-19 | 2024-09-30 | FORM 10-Q | 0001663577-24-000294 | View SEC Doc Filr Page |
| NT 10-Q | 2024-11-14 | 2024-09-30 | NOTIFICATION OF LATE FILING | 0001663577-24-000289 | View SEC Doc Filr Page |
| 8-K | 2024-10-03 | 2024-10-03 | FORM 8-K | 0001663577-24-000257 | View SEC Doc Filr Page |
| 10-Q | 2024-08-15 | 2024-06-30 | FORM 10-Q | 0001663577-24-000234 | View SEC Doc Filr Page |
| NT 10-Q | 2024-08-14 | 2024-06-30 | EXTENSION | 0001663577-24-000226 | View SEC Doc Filr Page |
| 8-K | 2024-06-04 | 2024-06-04 | FORM 8-K | 0001663577-24-000148 | View SEC Doc Filr Page |
| 8-K | 2024-05-29 | 2024-05-29 | FORM 8-K | 0001663577-24-000143 | View SEC Doc Filr Page |
| 10-Q | 2024-05-15 | 2024-03-31 | QUARTERLY REPORT | 0001663577-24-000137 | View SEC Doc Filr Page |
| 10-K | 2024-04-16 | 2023-12-31 | 10-K Filing | 0001663577-24-000119 | View SEC Doc Filr Page |
| NT 10-K | 2024-04-01 | 2023-12-31 | NT 10-K Filing | 0001663577-24-000095 | View SEC Doc Filr Page |
| 10-Q | 2023-11-15 | 2023-09-30 | 10-Q Filing | 0001663577-23-000536 | View SEC Doc Filr Page |
| NT 10-Q | 2023-11-15 | 2023-09-30 | NT 10-Q Filing | 0001663577-23-000534 | View SEC Doc Filr Page |
| 8-K | 2023-10-25 | 2023-10-17 | 8-K Filing | 0001663577-23-000514 | View SEC Doc Filr Page |
| 10-Q | 2023-08-14 | 2023-06-30 | 10-Q Filing | 0001663577-23-000402 | View SEC Doc Filr Page |
| 10-Q | 2023-05-10 | 2023-03-31 | 10-Q Filing | 0001663577-23-000234 | View SEC Doc Filr Page |
| 10-K | 2023-03-30 | 2022-12-31 | 10-K Filing | 0001663577-23-000137 | View SEC Doc Filr Page |